Regulation of factors controlling angiogenesis in liver development: A role for PEDF in the formation and maintenance of normal vasculature

Biochemical and Biophysical Research Communications

Volumn 325, Issue 2, 2004, Pages 408-413

  Sawant, S ^a   Aparicio, S ^a   Tink, A R ^a   Lara, N ^a   Barnstable, C J ^b   Tombran Tink, J ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Developmental expression; Hepatocellular carcinoma; Hepatocytes; Liver; PEDF; Tumor angiogenesis; VEGF isoforms

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOARCHITECTURE; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; EYE PROTEINS; GENE EXPRESSION; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIVER; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; PROTEIN ISOFORMS; RATS; RNA, MESSENGER; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 7644227333     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.041     Document Type: Article

References (32)

1. J. Folkman, and P.A. D'Amore Blood vessel formation: what is its molecular basis? Cell 87 1996 1153 1155
2. A. Bilkfalvi, and R. Bicknell Recent advances in angiogenesis, anti-angiogenesis and vascular targeting Trends Pharmacol. Sci. 23 2002 576 582
3. G. Gouysse, A. Couvelard, S. Frachon, R. Bouvier, M. Nejjari, M.C. Dauge, G. Feldmann, D. Henin, and J.Y. Scoazec Relationship between vascular development and vascular differentiation during liver organogenesis in humans J. Hepatol. 37 2002 730 740
4. Y. Wang, J. Luk, K. Ikeda, K. Man, A. Chu, K. Kaneda, and S. Fan Regulatory role of vHL/HIF-1α in hypoxia-induced VEGF production in hepatic stellate cells Biochem. Biophys. Res. Commun. 317 2004 358 362
5. J. Tombran-Tink, G. Chader, and V. Johnson PEDF: a pigment epithelium derived factor with potent neuronal differentiative activity Exp. Eye Res. 43 1991 1994 2000
6. D.W. Dawson, O.V. Volpert, P. Gillis, S.E. Crawford, H. Xu, W. Benedict, and N.P. Bouck Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 285 1999 245 248
7. J. Tombran-Tink, and C.J. Barnstable Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor Trends Mol. Med. 9 2003 244 250
8. J. Tombran-Tink, K. Mazuruk, I.R. Rodriguez, D. Chung, T. Linker, E. Englander, and G.J. Chader Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin Mol. Vis. 2 1996 11
9. V.K. Singh, G.J. Chader, and I.R. Rodriguez Structural and comparative analysis of the mouse gene for pigment epithelium-derived factor (PEDF) Mol. Vis. 4 1998 7
10. K.C. Behling, E.M. Surace, and J. Bennett Pigment epithelium-derived factor expression in the developing mouse eye Mol. Vis. 8 2002 449 454
11. N. Ogata, J. Tombran-Tink, M. Nishikawa, T. Nishimura, Y. Mitsuma, T. Sakamoto, and M. Matsumura Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment Am. J. Ophthalmol. 132 2001 378 382
12. J. Spranger, M. Osterhoff, M. Reimann, M. Mohlig, M. Ristow, M.K. Francis, V. Cristofalo, H.P. Hammes, G. Smith, M. Boulton, and A.F. Pfeiffer Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease Diabetes 50 2001 2641 2645
13. N. Ogata, M. Nishikawa, T. Nishimura, Y. Mitsuma, and M. Matsumura Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy Am. J. Ophthalmol. 134 2002 348 353
14. N. Ogata, M. Nishikawa, T. Nishimura, Y. Mitsuma, and M. Matsumura Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy Am. J. Ophthalmol. 133 2002 851 852
15. N.M. Holekamp, N. Bouck, and O. Volpert Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age related macular degeneration Am. J. Ophthalmol. 134 2002 220 227
16. B. Shi, X. Wang, and Z. Yang Vascular endothelial growth factors and liver diseases Hepatogastroenterology 48 2001 1145 1148
17. K. Kozaki, O. Miyasishi, O. Koiwai, Y. Yasui, A. Kashiwai, Y. Nishikawa, S. Shimizu, and S. Saga Isolation, purification and characterization of a collagen-associated serpin, caspin, produced by murine colon adenocarcinoma cells J. Biol. Chem. 273 1998 15125 15130
18. S. Li, Y. Chen, and H. Wei Muscle pigment epithelium-derived factor gene associating with tumorigenesis of B16 melanoma Clin. J. Pathol. 30 2001 281 284
19. J. Tombran-Tink, and C.J. Barnstable Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone Biochem. Biophys. Res. Comm. 316 2004 573 579
20. J. Tombran-Tink, N. Lara, S.E. Apricio, P. Potluri, S. Gee, J.-X. Ma, G. Chader, and C.J. Barnstable Retinoic acid and dexamethasone regulate the expression of PEDF in proliferating cells Exp. Eye Res. 78 2004 945 955
21. J. Tombran-Tink, and C.J. Barnstable PEDF: a multifaceted neurotrophic factor Nat. Rev. Neurosci. 4 2003 628 636
22. C.J. Barnstable, and J. Tombran-Tink Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential Prog. Retin. Eye Res. 23 2004 561 577
23. J. Tombran-Tink, S.M. Shivaram, G.J. Chader, L.V. Johnson, and D. Bok Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity J. Neurosci. 15 1995 4992 5003
24. S.V. Petersen, Z. Valnickova, and J.J. Enghild Pigment epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood. Purification and characterization Biochem. J. 374 2003 199 206
25. N. Ferrara Vascular endothelial growth factor: molecular and biological aspects Curr. Top. Microbiol. Immunol. 237 1999 1 30
26. C.J. Robinson, and S.E. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J. Cell Sci. 114 2001 853 865
27. Y.S. Ng, R. Rohan, M.E. Sunday, D.E. Demello, and P.A. D'Amore Differential expression of VEGF isoforms in mouse during development and in the adult Dev. Dyn. 220 2001 112 121
28. P. Guo, L. Xu, S. Pan, R.A. Brekken, S.T. Yang, G.B. Whitaker, M. Nagane, P.E. Thorpe, J.S. Rosenbaum, H.J.S. Huang, W.K. Cavenee, and S.Y. Cheng Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites Cancer Res. 61 2001 8569 8577
29. K. Ohno-Matsui, I. Morita, J. Tombran-Tink, D. Mrazek, M. Onodera, T. Uetama, M. Hayano, S.I. Murota, and M. Mochizuki Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF J. Cell Physiol. 189 2001 323 333
30. B.M. Fenton, S.F. Paoni, W. Liu, S.-Y. Cheng, B. Hu, and I. Ding Overexpression of VEGF121, but not VEGF165 or FGF-1, improves oxygenation in MCF-7 breast tumours Br. J. Cancer 90 2004 430 435
31. J.L. Yu, J.W. Rak, G. Klement, and R.S. Kerbel Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts Cancer Res. 62 2002 1838 1846
32. S.Y. Cheng, M. Nagane, H.S. Huang, and W.K. Cavenee Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189 Proc. Natl. Acad. Sci. USA 94 1997 12081 12087